MXPA05012219A - Vacuna aviar combinada contra e. coli y salmonella. - Google Patents

Vacuna aviar combinada contra e. coli y salmonella.

Info

Publication number
MXPA05012219A
MXPA05012219A MXPA05012219A MXPA05012219A MXPA05012219A MX PA05012219 A MXPA05012219 A MX PA05012219A MX PA05012219 A MXPA05012219 A MX PA05012219A MX PA05012219 A MXPA05012219 A MX PA05012219A MX PA05012219 A MXPA05012219 A MX PA05012219A
Authority
MX
Mexico
Prior art keywords
coli
combination
salmonella
avian
vaccine against
Prior art date
Application number
MXPA05012219A
Other languages
English (en)
Inventor
Mahesh Kumar
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of MXPA05012219A publication Critical patent/MXPA05012219A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1092—3-Phosphoshikimate 1-carboxyvinyltransferase (2.5.1.19), i.e. 5-enolpyruvylshikimate-3-phosphate synthase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se proporciona una composicion de vacuna que comprende una combinacion de un microorganismo mutante de supresion genetica S. typhimurium y un microorganismo mutante de supresion genetica E. coli, adecuada para la aplicacion masiva a aves de corral. Tambien se proporciona un metodo seguro y efectivo para proteger a las aves de corral contra las devastaciones de las infecciones y enfermedades por E. coli y Salmonella.
MXPA05012219A 2003-05-14 2004-05-12 Vacuna aviar combinada contra e. coli y salmonella. MXPA05012219A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47047003P 2003-05-14 2003-05-14
PCT/US2004/014836 WO2004103401A2 (en) 2003-05-14 2004-05-12 Avian combination-vaccine against e.coli and salmonella

Publications (1)

Publication Number Publication Date
MXPA05012219A true MXPA05012219A (es) 2006-02-08

Family

ID=33476713

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05012219A MXPA05012219A (es) 2003-05-14 2004-05-12 Vacuna aviar combinada contra e. coli y salmonella.

Country Status (14)

Country Link
US (1) US7297338B2 (es)
EP (1) EP1622643A2 (es)
JP (2) JP5500762B2 (es)
KR (1) KR101150318B1 (es)
CN (2) CN102274495A (es)
AR (1) AR044339A1 (es)
AU (1) AU2004240585B2 (es)
BR (1) BRPI0410355B1 (es)
CA (1) CA2524939C (es)
MX (1) MXPA05012219A (es)
NZ (1) NZ543558A (es)
TW (1) TW200503755A (es)
WO (1) WO2004103401A2 (es)
ZA (1) ZA200509982B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7357935B2 (en) * 2003-05-14 2008-04-15 Wyeth Avian E. coli vaccine for protection against colibacillosis
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
MX343802B (es) 2008-09-26 2016-11-23 Ambrx Inc Microorganismos y vacunas dependientes de replicacion de aminoacidos no naturales.
CN102140430B (zh) * 2011-01-13 2013-10-23 河南科技大学 一种不含抗性标记的鼠伤寒沙门氏菌基因缺失突变菌株、疫苗及应用
KR101518872B1 (ko) * 2013-05-14 2015-05-22 대한민국(관리부서 : 농림축산식품부 농림축산검역본부) 가금의 세균성 전신성 질병 원인균 진단용 프라이머 세트 및 상기 프라이머 세트를 포함하는 진단 키트
CN104711365B (zh) * 2015-04-02 2018-06-12 青岛康伦生物科技有限公司 沙门菌和大肠杆菌o78多重pcr快速检测的试剂盒
CN112618706B (zh) * 2020-11-21 2021-09-14 青岛博霖生物科技有限公司 沙门氏菌、鸭疫里默氏杆菌、大肠埃希氏杆菌病三联疫苗

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US400958A (en) * 1889-04-09 Leading-in apparatus for conduits
US650733A (en) * 1899-06-23 1900-05-29 William A Shaw Fire-escape.
GB8912330D0 (en) 1989-05-30 1989-07-12 Wellcome Found Live vaccines
JPH07206705A (ja) 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ（ｉｎ ｏｖｏ）ワクチン
GB9806449D0 (en) * 1998-03-25 1998-05-27 Peptide Therapeutics Ltd Attenuated bacteria useful in vaccines
US7357935B2 (en) * 2003-05-14 2008-04-15 Wyeth Avian E. coli vaccine for protection against colibacillosis

Also Published As

Publication number Publication date
AU2004240585B2 (en) 2010-08-19
KR20060012001A (ko) 2006-02-06
JP2012131796A (ja) 2012-07-12
CN102274495A (zh) 2011-12-14
CA2524939A1 (en) 2004-12-02
CA2524939C (en) 2012-12-04
BRPI0410355B1 (pt) 2016-09-13
NZ543558A (en) 2008-02-29
BRPI0410355A (pt) 2006-07-04
ZA200509982B (en) 2011-05-25
EP1622643A2 (en) 2006-02-08
US7297338B2 (en) 2007-11-20
KR101150318B1 (ko) 2012-06-08
CN1787836A (zh) 2006-06-14
JP2006528979A (ja) 2006-12-28
WO2004103401A3 (en) 2005-02-10
AR044339A1 (es) 2005-09-07
WO2004103401A2 (en) 2004-12-02
JP5500762B2 (ja) 2014-05-21
AU2004240585A1 (en) 2004-12-02
US20040234550A1 (en) 2004-11-25
TW200503755A (en) 2005-02-01

Similar Documents

Publication Publication Date Title
CY1107188T1 (el) Εμβολιο ε. coli πτηνου για την προστασια εναντι κολοβακτηριωσης
BR9508633A (pt) Composição preparação de vacina estojo e processos para criar ou sustentar uma resposta imune protetora ou adaptadora a um antígeno em um hospedeiro e para induzir uma resposta imune protetora contra um organismo bacteriano enterotóxico
ES2173300T3 (es) Vacunas de virus vivos prrs de baja patogenicidad y metodos para su preparacion.
MXPA05012219A (es) Vacuna aviar combinada contra e. coli y salmonella.
WO2001060849A3 (en) Cold-adapted equine influenza viruses
MY144492A (en) Human papillomavirus vaccine comprising hpv 16 and hpv 18 virus like particles, which induce cross protection against other hpv types
EP1471936A4 (en) HIV VACCINE AND METHOD OF USE
ES2192949A1 (es) Disminucion de la virulencia de mycobacterium tuberculosis por la inactivacion del gen phop.
MXPA03009763A (es) Vacuna contra el virus de la enfermedad de la fiebre aftosa.
NL300121I2 (nl) Nieuwe bacterie die een pluimveeziekte veroorzaakten een daarvan afgeleid vaccin.
AR009650A1 (es) Mycoplasma synoviae atenuado vivo, su uso, un cultivo microbiologico que lo comprende, una vacuna bacteriana atenuada viva para la proteccion de las aves de corral contra la infeccion por mycoplasma synoviae y un metodo para preparar dicha vacuna.
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
WO2003032917A3 (en) Hookworm vaccine
ATE359815T1 (de) Streptococcus-phocae-vakzine
JP2003528139A5 (es)
PL348550A1 (en) Ibdv mutant, vaccine containing it for protecting poultry against a disease caused by ibdv and method of protecting poultry against such disease
WO2004020585A3 (en) Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry
TW200510379A (en) 1, 4-disubstituted piperidine compounds, their preparation and use as medicaments
TW200517120A (en) Protein from Photobacterium damselae and use thereof
DE60238554D1 (de) Vakzine gegen infektionskrankheiten
ATE495757T1 (de) Attenuierte bakterielle lebendvakzine
TH61115B (th) สารผสมของวัคซีนสัตว์ปีกสำหรับป้องกันสัตว์ปีกจากโรคและการติดเชื้อที่มีสาเหตุมาจาก E.coli และซาโมเนลลา
TH86935B (th) วัคซีน E.coli ของสัตว์ปีกสำหรับป้องกันโรคโคไลบาซิลโลซิส
RU94023835A (ru) Вакцина микродерм против дерматофитозов животных
UA62746C2 (en) Emulsion vaccine associated inactivated against newcastle disease, infectious bronchitis of fowls, and syndrome of decreasing egg production-76

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights
HC Change of company name or juridical status